Skip to main content

Biovie Inc.

BIVI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001580149

In the last 90 days, Biovie Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $2.86M in total; no superinvestor holds it.

Other share classesBIVIW

Superinvestors holding BIVI, Q2 2026

See all superinvestors

No superinvestor reported holding BIVI in Q2 2026.